MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
40.83
+2.47
+6.44%
After Hours: 40.83 0 0.00% 19:59 02/06 EST
OPEN
39.01
PREV CLOSE
38.36
HIGH
40.85
LOW
38.68
VOLUME
1.38M
TURNOVER
--
52 WEEK HIGH
117.33
52 WEEK LOW
32.99
MARKET CAP
4.29B
P/E (TTM)
46.09
1D
5D
1M
3M
1Y
5Y
1D
Average Software Stock Now Down Since Tariff Tantrum Lows
Seeking Alpha · 17h ago
Chief Development Officer William Guyer Reports Disposal of Corcept Therapeutics Common Shares
Reuters · 1d ago
Stock Picks From Seeking Alpha's January 2026 New Analysts
Seeking Alpha · 1d ago
Allspring Emerging Growth Fund Q4 2025 Performance Review
Seeking Alpha · 2d ago
Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 2d ago
Xeris Biopharma: Strong Recorlev Momentum And Pipeline Opportunity
Seeking Alpha · 3d ago
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
PR Newswire · 4d ago
Corcept TherapeuticCRL does not change investment thesis, says Canaccord
TipRanks · 4d ago
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.